Human Otoraplin (Recombinant)

Human Otoraplin (Recombinant) is purified from E.Coli to achieve a single, non-glycosylated polypeptide chain with 111 amino acids. It contributes to melanoma inhibition and the initiation of periotic mesenchyme chondrogenesis, as well as cartilage development and maintenance.